Osteoporosis in women with breast cancer.
- 1 February 2003
- journal article
- review article
- Published by Springer Nature in Current Oncology Reports
- Vol. 5 (1) , 53-57
- https://doi.org/10.1007/s11912-003-0086-7
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Effect of Letrozole Versus Placebo on Bone Mineral Density in Women With Primary Breast Cancer Completing 5 or More Years of Adjuvant Tamoxifen: A Companion Study to NCIC CTG MA.17Journal of Clinical Oncology, 2006
- Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trialThe Lancet, 2002
- Prevention and Treatment of Osteoporosis in Women With Breast CancerMayo Clinic Proceedings, 2000
- Alendronate and Estrogen–Progestin in the Long-Term Prevention of Bone Loss: Four-Year Results from the Early Postmenopausal Intervention Cohort Study: A Randomized, Controlled TrialAnnals of Internal Medicine, 1999
- Endogenous Hormones and the Risk of Hip and Vertebral Fractures among Older WomenNew England Journal of Medicine, 1998
- Physical Activity and Osteoporotic Fracture Risk in Older WomenAnnals of Internal Medicine, 1998
- Hormonal Predictors of Bone Loss in Elderly Women: A Prospective StudyJournal of Bone and Mineral Research, 1998
- A two-year program of aerobics and weight training enhances bone mineral density of young womenJournal of Bone and Mineral Research, 1995
- Effects of Tamoxifen on Bone Mineral Density in Postmenopausal Women with Breast CancerNew England Journal of Medicine, 1992
- Use of calcitonin in the treatment of bone pain associated with osteoporosisCalcified Tissue International, 1991